aminoimidazole carboxamide has been researched along with Lymph Node Metastasis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Crispen, R; Das Gupta, TK; El-Domeiri, AA; Sabet, TY; Simo, C; Trippon, M | 1 |
Balch, CM; Boddie, AW; Edwards, MJ; McBride, CM; Soong, SJ | 1 |
3 other study(ies) available for aminoimidazole carboxamide and Lymph Node Metastasis
Article | Year |
---|---|
[Malignant melanoma].
Topics: Aminoimidazole Carboxamide; BCG Vaccine; Carmustine; Humans; Lymphatic Metastasis; Melanoma; Neck Dissection; Neoplasm Metastasis; Parotid Gland; Radiotherapy Dosage | 1981 |
Adjuvant chemotherapy and immunotherapy in high risk patients with melanoma.
Topics: Adult; Aged; Aminoimidazole Carboxamide; BCG Vaccine; Dacarbazine; Evaluation Studies as Topic; Female; Follow-Up Studies; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Postoperative Care; Risk; Skin Neoplasms; Triazenes | 1978 |
Isolated limb perfusion for localized melanoma of the extremity. A matched comparison of wide local excision with isolated limb perfusion and wide local excision alone.
Topics: Aminoimidazole Carboxamide; Antineoplastic Agents; Arm; Chemotherapy, Cancer, Regional Perfusion; Combined Modality Therapy; Humans; Leg; Lymphatic Metastasis; Melanoma; Melphalan; Middle Aged; Prognosis; Skin Neoplasms; Survival Rate | 1990 |